Generate Biomedicines, Inc. (GENB)

Generate Biomedicines will go public soon. The estimated IPO date is February 27, 2026.

IPO Price Range

$15.00 - $17.00

Shares Offered

25,000,000

Deal Size

$400.00M

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	2,039	-	-
Enterprise Value	1,886	-	-
Debt / Equity Ratio	-0.11	-0.11	-0.18
Debt / EBITDA Ratio	-0.30	-0.30	-0.41
Debt / FCF Ratio	-0.34	-0.34	-0.64
Net Debt / Equity Ratio	0.25	0.25	0.73
Net Debt / EBITDA Ratio	0.68	0.68	1.70
Net Debt / FCF Ratio	0.75	0.75	2.62
Quick Ratio	2.70	2.70	4.56
Return on Equity (ROE)	36.20%	36.20%	41.74%
Return on Assets (ROA)	-67.53%	-67.53%	-35.00%
Return on Capital Employed (ROCE)	-94.90%	-94.90%	-45.68%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).